T1	Participants 47 90	previously untreated advanced breast cancer
T2	Participants 624 678	previously untreated metastatic breast cancer patients
T3	Participants 1232 1490	Patients had to have histologically documented measurable breast cancer and a performance status of 0-1. Patients could not have had prior chemotherapy for metastatic disease. Prior adjuvant chemotherapy was permitted. Patients could not have visceral crisis
T4	Participants 2226 2269	previously untreated breast cancer patients
